Theorem Clinical Research, a CRO specializing in complex trials, has announced the formation of a strategic alliance with BioTelemetry. BioTelemetry’s Clinical Research division includes Cardiocore, a global cardiac core laboratory.

Joseph Capper, BioTelemetry CEO, said, “Theorem’s experience in complex protocols aligns with our specialized cardiovascular testing services. The partnership complements BioTelemetry’s position that spans from clinical research through post-market surveillance and into clinical practice.  Both companies support trials in all clinical phases of pharmaceutical and biotech development and will collaborate globally within this alliance.” 

“Trends in the industry such as safety monitoring boards, translational medicine and risk-based monitoring put additional pressures on the clinical trial process to be faster, safer and more efficient,” said John Potthoff, Theorem president and CEO. “Our partnership with BioTelemetry allows us to meet those industry standards for our clients.”